Clinical Trial Update: Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy [Phase 2]

View source ↗

Summary

Amgen-sponsored Phase 2 trial evaluating a treatment for anemia in patients with gynecologic cancers undergoing chemotherapy; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Gynecologic Cancer

Snippet

Sponsor: Amgen | Conditions: Gynecological Malignancies, Genital Neoplasms, Female | Phase 2 | Status: COMPLETED